Literature DB >> 189623

Protriptyline: an effective agent in the treatment of the narcolepsy-cataplexy syndrome and hypersomnia.

H S Schmidt, R W Clark, P R Hyman.   

Abstract

The authors present five case reports illustrating that 10-20 mg of protriptyline in a single dose at bedtime can effectively control arousal dysfunction (sleep drunkenness and hypersomnia) and the narcolepsycataplexy syndrome without the apparent development of tolerance and without the side effects that are frequent complications of treatment with other agents. Although protriptyline was efficacious in controlling symptoms, it was found to have relatively poor REM sleep-suppressing properties.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 189623     DOI: 10.1176/ajp.134.2.183

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  12 in total

Review 1.  Treatment options for sleep apnoea.

Authors:  R R Grunstein; J Hedner; L Grote
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Waking up is the hardest thing I do all day: Sleep inertia and sleep drunkenness.

Authors:  Lynn M Trotti
Journal:  Sleep Med Rev       Date:  2016-09-04       Impact factor: 11.609

3.  The ophthalmologist and narcolepsy, or why are so many ophthalmologists caught napping?

Authors:  J A Dyer; E S Eisenberg
Journal:  Trans Am Ophthalmol Soc       Date:  1982

Review 4.  Treatment of the obstructive sleep apnea syndrome.

Authors:  R V Wiggins; W W Schmidt-Nowara
Journal:  West J Med       Date:  1987-11

Review 5.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

6.  Effects of protriptyline on vigilance and information processing in narcolepsy.

Authors:  G K Henry; R P Hart; J A Kwentus; M J Sicola
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 7.  Narcolepsy in the older adult: epidemiology, diagnosis and management.

Authors:  Sangeeta S Chakravorty; David B Rye
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Fluvoxamine and clomipramine in the treatment of cataplexy.

Authors:  M Schachter; J D Parkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-02       Impact factor: 10.154

9.  Protriptyline in the treatment of sleep apnoea.

Authors:  W A Conway; F Zorick; P Piccione; T Roth
Journal:  Thorax       Date:  1982-01       Impact factor: 9.139

10.  Narcolepsy.

Authors:  M M Mitler; R Hajdukovic; M Erman; J A Koziol
Journal:  J Clin Neurophysiol       Date:  1990-01       Impact factor: 2.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.